Sort
51,593 grants matching “hepatitis”
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
$575,250Neil J. Freedman · Duke University · R01 · FY2024 · HL
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study
$575,175Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
REGULATION OF HEPATITIS B VIRUS TRANSCRIPTION
$575,166Scripps Research Institute · R01 · FY2002 · AI
Hepatitis C virus genome structure: dynamic roles in replication and infectivity
$575,125Anna Marie Pyle · Yale University · R01 · FY2019 · AI
High Expression Recombinant Factor VIII
$575,118Christopher Bradley Doering · Expression Therapeutics · R42 · FY2010 · HL
Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression
$575,035Jeffrey E Pessin · Albert Einstein College Of Medicine · R01 · FY2024 · DK
Adipose MTP and FIT2 in the regulation of plasma lipids, obesity and atherosclerosis
$574,999M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
Orally Active Nucleoside Phosphonates for Hepatitis C Virus
$574,983Robert Turner Schooley · University Of California, San Diego · R01 · FY2009 · AI
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance
$574,937Qing Miao · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2024 · DK
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
$574,875Holden H Wu · University Of California Los Angeles · U01 · FY2023 · EB
Regulation of Rhythmic m6A RNA Modification by ERâassociated Degradation
$574,804Kezhong Zhang · Wayne State University · R01 · FY2021 · DK
GENETIC ANALSIS OF CELL TYPE SPECIFIC FUNCTIONS
$574,784Fred Hutchinson Cancer Research Center · R01 · FY2002 · GM
Drug-gene-nutraceutical interactions of cannabidiol
$574,696Michael Thomas Eadon · Indiana University Indianapolis · R01 · FY2025 · AT
INTEGRATING PHYSICAL AND MENTAL CARE FOR ADULTS WITH SERIOUS MENTAL ILLNESS
$574,544Joshua A Breslau · Rand Corporation · R01 · FY2014 · MH
Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities
$574,518Lloyd A Goldsamt · New York University · R01 · FY2015 · DA
Outcome of NASH in Adolescents after Bariatric Surgery vs. Lifestyle Intervention
$574,508Stavra Xanthakos · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · DK
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$574,395Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · DK
METHADONE AND HIV DRUG INTERACTIONS
$574,344Evan D Kharasch · Washington University · R01 · FY2010 · DA
Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy
$574,214William Nicholas Haining · Massachusetts General Hospital · U19 · FY2014 · AI
Mechanisms of Insulin Resistance in Man
$574,150Rita Basu · Mayo Clinic Rochester · R01 · FY2012 · DK
Technology-Dev-Core
$574,115Sally M McFall · Northwestern University · U54 · FY2022 · EB
Acoustic Radiation Force Based Hepatic Elasticity Quantification and Imaging
$574,067Kathryn R Nightingale · Duke University · R01 · FY2015 · EB
African American Female Drug Users: HIV, Health Disparities, & Criminality
$574,039Carrie Beth Oser · University Of Kentucky · R01 · FY2008 · DA
REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISM
$574,035University Of Texas Hlth Sci Ctr San Ant · R01 · FY2004 · DK
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
$574,001Jessie Nedrow · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA